fda compounding glp-1 warning letters october 2025 issued 25 to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Drug Recalls and Warnings:

What to know about the headlines.

This analysis of survey data finds that over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug though relatively few have a claim, suggesting that a much smaller share seeks treatment through healthcare providers.

Inconsistent use of some GLP-1 weight-loss medications may significantly lessen their effectiveness, according to a new preclinical study.

Calm Inflammation Clear Your Mind Sleep Deep Low-Dose Naltrexone (LDN) is the tiny nightly capsule that turns down hidden inflammation, releases feel-good endorphins, and lets your body repair while you rest